Pendal Group LTD Bristol Myers Squibb CO Transaction History
Pendal Group LTD
- $12.2 Billion
- Q4 2022
A detailed history of Pendal Group LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pendal Group LTD holds 8,767 shares of BMY stock, worth $482,009. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,767
Previous 12,988
32.5%
Holding current value
$482,009
Previous $924,000
31.82%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding BMY
# of Institutions
2,749Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.72 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.28 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.23 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.32 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $117B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...